Background and Aims The long‐term risk of disease for patients with nonalcoholic fatty liver
disease (NAFLD) in the absence of elevated enzymes is unclear. We conducted a …

OBJECTIVE: To evaluate the association between non-alcoholic fatty liver disease and all
cause and cause specific mortality in a representative sample of the US general population …

Most patients with nonalcoholic fatty liver disease (NAFLD) are overweight or obese.
However, a significant proportion of patients have a normal body mass index (BMI), denoted …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver
diseases in developed countries, and its prevalence and incidence are rapidly increasing …

Background & Aims The natural history of lean nonalcoholic fatty liver disease (NAFLD) is
not well-understood. Consequently, patient counseling and disease management are …

Background Given the association of NAFLD with metabolic risks, a name change to MAFLD
is proposed. We compared the long‐term outcomes of NAFLD and MAFLD. Methods We …

Backgrounds Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and metabolic
syndrome conditions. However, a subset of NAFLD patients express a normal or low body …

'Is life worth living? It all depends on the liver'(American philosopher William James [1842—
1910]) Non-alcoholic fatty liver disease (NAFLD) is currently the most frequent global liver …

Background With its increasing incidence, nonalcoholic fatty liver disease (NAFLD) is of
particular concern in the Veterans Health Administration (VHA). Aims To evaluate risk factors …

Background Risk factors and timing associated with disease progression and mortality in
nonalcoholic fatty liver disease (NAFLD) are poorly understood. Aims To evaluate the impact …